194 related articles for article (PubMed ID: 11278768)
1. Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes.
Shakibaei M; Schulze-Tanzil G; de Souza P; John T; Rahmanzadeh M; Rahmanzadeh R; Merker HJ
J Biol Chem; 2001 Apr; 276(16):13289-94. PubMed ID: 11278768
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
Hu Y; Bally M; Dragowska WH; Mayer L
Mol Cancer Ther; 2003 Jul; 2(7):641-9. PubMed ID: 12883037
[TBL] [Abstract][Full Text] [Related]
3. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
4. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
5. ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status.
Kim SJ; Ju JW; Oh CD; Yoon YM; Song WK; Kim JH; Yoo YJ; Bang OS; Kang SS; Chun JS
J Biol Chem; 2002 Jan; 277(2):1332-9. PubMed ID: 11689560
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
Watanabe H; de Caestecker MP; Yamada Y
J Biol Chem; 2001 Apr; 276(17):14466-73. PubMed ID: 11278290
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway.
Yagi R; McBurney D; Horton WE
J Biol Chem; 2005 Aug; 280(34):30517-25. PubMed ID: 15975921
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase.
Yoon YM; Kim SJ; Oh CD; Ju JW; Song WK; Yoo YJ; Huh TL; Chun JS
J Biol Chem; 2002 Mar; 277(10):8412-20. PubMed ID: 11744731
[TBL] [Abstract][Full Text] [Related]
10. Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes.
Yammani RR; Loeser RF
Arthritis Res Ther; 2012 Jan; 14(1):R23. PubMed ID: 22289259
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
12. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
Yip-Schneider MT; Schmidt CM
Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
Fukazawa H; Noguchi K; Murakami Y; Uehara Y
Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 induction of aggrecanase gene expression in human articular chondrocytes is mediated by mitogen-activated protein kinases.
Sylvester J; El Mabrouk M; Ahmad R; Chaudry A; Zafarullah M
Cell Physiol Biochem; 2012; 30(3):563-74. PubMed ID: 22832115
[TBL] [Abstract][Full Text] [Related]
15. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK).
Yosimichi G; Nakanishi T; Nishida T; Hattori T; Takano-Yamamoto T; Takigawa M
Eur J Biochem; 2001 Dec; 268(23):6058-65. PubMed ID: 11732999
[TBL] [Abstract][Full Text] [Related]
16. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.
Wiesenauer CA; Yip-Schneider MT; Wang Y; Schmidt CM
J Am Coll Surg; 2004 Mar; 198(3):410-21. PubMed ID: 14992744
[TBL] [Abstract][Full Text] [Related]
17. NaF activates MAPKs and induces apoptosis in odontoblast-like cells.
Karube H; Nishitai G; Inageda K; Kurosu H; Matsuoka M
J Dent Res; 2009 May; 88(5):461-5. PubMed ID: 19493891
[TBL] [Abstract][Full Text] [Related]
18. Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis.
Orlowski RZ; Small GW; Shi YY
J Biol Chem; 2002 Aug; 277(31):27864-71. PubMed ID: 12023956
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen.
Richards JD; Davé SH; Chou CH; Mamchak AA; DeFranco AL
J Immunol; 2001 Mar; 166(6):3855-64. PubMed ID: 11238629
[TBL] [Abstract][Full Text] [Related]
20. The p44/42 mitogen-activated protein kinase cascade is involved in the induction and maintenance of astrocyte stellation mediated by protein kinase C.
Abe K; Saito H
Neurosci Res; 2000 Mar; 36(3):251-7. PubMed ID: 10683529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
